Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, will host its quarterly conference call today, Thursday, November 6, 2014 at 4:00 PM EST.
The purpose of the call is to update the market in general and shareholders in particular about developments at the Company. In particular, the Company wishes to discuss the completion of the due diligence audit of the Company’s regulatory documents for PV-10 and PH-10. In addition, the Company will update callers on the status of the Memorandum of Understanding (“MOU”) it signed with Sinopharm-China State Institute of Pharmaceutical Industry and Sinopharm A-THINK Pharmaceutical Co., Ltd. This MOU focuses on a definitive licensing contract.
Help employers find you! Check out all the jobs and post your resume.
